The science-based economy: The role of health research
Article
It is important we prioritise health research and development, including basic science, public health, behavioural science, and innovation development. The UK’s health sector has clear strengths. It has an enviable academic base, delivers strong return on investment, and is home to an exciting range of businesses with the potential to grow. As we build the role of science in our economy, health research and the life sciences should be a central pillar in our approach.
But we need a strategy to maximise gains. Health research and the life sciences can provide significant value – for our economy, society, and health. However, we will not maximise that value without a coherent strategy. The new 'R&D Roadmap' has begun that process for the research and development as a whole. However, we need to translate that into specific, bold strategies for strength R&D areas – like health and the life sciences.
This report outlines a progressive approach, based on three central pillars.
Related items

Restoring security: Understanding the effects of removing the two-child limit across the UK
The government’s decision to lift the two-child limit marks one of the most significant changes to the social security system in a decade.
Building a healthier, wealthier Britain: Launching the IPPR Centre for Health and Prosperity
Following the success of our Commission on Health and Prosperity, IPPR is excited to launch the Centre for Health and Prosperity.
A ‘paradigm shift’ in asylum and immigration policy?
In 2019, a package of asylum reforms known as the ‘paradigm shift’ was passed by a broad party consensus in the Danish parliament.